BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15557624)

  • 21. Efficacy of a
    Moustafa DA; DiGiandomenico A; Raghuram V; Schulman M; Scarff JM; Davis MR; Varga JJ; Dean CR; Goldberg JB
    Infect Immun; 2023 Dec; 91(12):e0024723. PubMed ID: 37991349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
    Johansen HK; Høiby N; Pedersen SS
    APMIS; 1991 Dec; 99(12):1061-8. PubMed ID: 1772641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.
    Bumann D
    Infect Immun; 2001 Dec; 69(12):7493-500. PubMed ID: 11705925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain.
    Tang IK; Ji DD; Chou CF; Lin HC; Liao CL; Sytwu HK; Wang JJ; Liu YT
    J Microbiol Immunol Infect; 2002 Dec; 35(4):229-35. PubMed ID: 12542248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein.
    Poirier TP; Kehoe MA; Beachey EH
    J Exp Med; 1988 Jul; 168(1):25-32. PubMed ID: 3294331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.
    Guzmán CA; Brownlie RM; Kadurugamuwa J; Walker MJ; Timmis KN
    Infect Immun; 1991 Dec; 59(12):4391-7. PubMed ID: 1937797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin.
    Toth A; Schödel F; Duchêne M; Massarrat K; Blum B; Schmitt A; Domdey H; von Specht BU
    Vaccine; 1994 Oct; 12(13):1215-21. PubMed ID: 7839727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.
    Karem KL; Chatfield S; Kuklin N; Rouse BT
    Infect Immun; 1995 Dec; 63(12):4557-63. PubMed ID: 7591105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.
    Pasetti MF; Pickett TE; Levine MM; Sztein MB
    Vaccine; 2000 Aug; 18(28):3208-13. PubMed ID: 10869765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
    Priebe GP; Brinig MM; Hatano K; Grout M; Coleman FT; Pier GB; Goldberg JB
    Infect Immun; 2002 Mar; 70(3):1507-17. PubMed ID: 11854239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clearance of Pseudomonas aeruginosa from normal rat lungs after immunization with somatic antigens or toxin A.
    Johansen HK; Cryz SJ; Høiby N
    APMIS; 1994 Jul; 102(7):545-53. PubMed ID: 7917224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.
    Redman TK; Harmon CC; Michalek SM
    Infect Immun; 1994 Aug; 62(8):3162-71. PubMed ID: 8039885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses.
    Medina E; Paglia P; Nikolaus T; Müller A; Hensel M; Guzmán CA
    Infect Immun; 1999 Mar; 67(3):1093-9. PubMed ID: 10024548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal vaccination targeting the receptor binding domains of
    Winter K; Houle S; Dozois CM; Ward BJ
    Microbiol Spectr; 2024 Feb; 12(2):e0310922. PubMed ID: 38189293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.
    Kozarov E; Miyashita N; Burks J; Cerveny K; Brown TA; McArthur WP; Progulske-Fox A
    Infect Immun; 2000 Feb; 68(2):732-9. PubMed ID: 10639440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain.
    Lindberg AA; Segall T; Weintraub A; Stocker BA
    Infect Immun; 1993 Apr; 61(4):1211-21. PubMed ID: 7681041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
    Finke M; Duchêne M; Eckhardt A; Domdey H; von Specht BU
    Infect Immun; 1990 Jul; 58(7):2241-4. PubMed ID: 2114360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
    Price BM; Galloway DR; Baker NR; Gilleland LB; Staczek J; Gilleland HE
    Infect Immun; 2001 May; 69(5):3510-5. PubMed ID: 11292786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
    Cripps AW; Dunkley ML; Clancy RL
    Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with live aroA recombinant Salmonella typhimurium producing invasin inhibits intestinal translocation of Yersinia pseudotuberculosis.
    Simonet M; Fortineau N; Beretti JL; Berche P
    Infect Immun; 1994 Mar; 62(3):863-7. PubMed ID: 8112856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.